189 related articles for article (PubMed ID: 15658413)
1. [Factor IX and factor IX inhibitor].
Higasa S
Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413
[No Abstract] [Full Text] [Related]
2. [Factor VII].
Nagaizumi K; Fukutake K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():636-9. PubMed ID: 15658410
[No Abstract] [Full Text] [Related]
3. [Clinical significance of factor IX analysis in blood coagulation tests].
Kakishita E; Nishida Y
Nihon Rinsho; 1989 Dec; 48 Suppl():834-6. PubMed ID: 2622013
[No Abstract] [Full Text] [Related]
4. [Factor XIII].
Takahashi I; Fukue H
Nihon Rinsho; 2004 Dec; 62 Suppl 12():660-2. PubMed ID: 15658417
[No Abstract] [Full Text] [Related]
5. Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder.
Girolami A; Burul A; Cappellato G; Dal Bo Zanon R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):65-71. PubMed ID: 88391
[TBL] [Abstract][Full Text] [Related]
6. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
Orstavik KH
Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
[TBL] [Abstract][Full Text] [Related]
7. [Thrombo test (TBT), hepaplastin test (HPT)].
Mitsuhashi H
Nihon Rinsho; 2004 Dec; 62 Suppl 12():594-6. PubMed ID: 15658398
[No Abstract] [Full Text] [Related]
8. [Prothrombin time].
Shimazu C
Nihon Rinsho; 2004 Dec; 62 Suppl 12():586-9. PubMed ID: 15658396
[No Abstract] [Full Text] [Related]
9. [Factor V].
Amano K; Fukutake K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():632-5. PubMed ID: 15658409
[No Abstract] [Full Text] [Related]
10. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
Orstavik KH
Br J Haematol; 1981 May; 48(1):15-23. PubMed ID: 6788066
[TBL] [Abstract][Full Text] [Related]
11. [TF (tissue factor), TFPI (tissue factor pathway inhibitor)].
Mori Y; Wada H
Nihon Rinsho; 2004 Dec; 62 Suppl 12():629-31. PubMed ID: 15658408
[No Abstract] [Full Text] [Related]
12. Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B.
Pouplard C; Trossaert M; LE Querrec A; Delahousse B; Giraudeau B; Gruel Y
Haemophilia; 2009 Jan; 15(1):365-8. PubMed ID: 18811593
[No Abstract] [Full Text] [Related]
13. [Factor VIII and factor VIII inhibitor].
Takamatsu J
Nihon Rinsho; 2004 Dec; 62 Suppl 12():640-2. PubMed ID: 15658411
[No Abstract] [Full Text] [Related]
14. Hemostatic disorders.
McPhee SJ; Bell WR
Compr Ther; 1981 Nov; 7(11):40-6. PubMed ID: 6976251
[No Abstract] [Full Text] [Related]
15. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
[TBL] [Abstract][Full Text] [Related]
16. [Anti-calmodulin antibody].
Hashimoto N; Ikeda Y; Toda G
Nihon Rinsho; 2010 Jun; 68 Suppl 6():697-700. PubMed ID: 20942167
[No Abstract] [Full Text] [Related]
17. [Immunologic tests: Anti-calmodulin antibody].
Ikeda Y; Hashimoto N
Nihon Rinsho; 2005 Jul; 63 Suppl 7():627-9. PubMed ID: 16111352
[No Abstract] [Full Text] [Related]
18. [Alpha2-plasmin inhibitor (alpha2PI)].
Mimuro J
Nihon Rinsho; 2004 Dec; 62 Suppl 12():708-10. PubMed ID: 15658430
[No Abstract] [Full Text] [Related]
19. An immunological method for detection of the carrier of hemophilia B.
Matsuoka M; Ito M; Takahashi K; Sakuragawa N
Thromb Haemost; 1976 Nov; 36(2):441-50. PubMed ID: 1036844
[TBL] [Abstract][Full Text] [Related]
20. Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
Takahashi I; Kato K; Sugiura I; Takamatsu J; Kamiya T; Saito H
J Lab Clin Med; 1991 Oct; 118(4):317-25. PubMed ID: 1940573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
